Trial ID 20289 | Maryland Oncology Hematology Trial ID 20289 – Maryland Oncology Hematology

Trial ID 20289

Trial Information - Phase I

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

Protocol ID: SGNTGT-001

Sponsor: Seagen, Inc.

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Gastric / GE Junction

Investigator

Wallmark MD, John

Status

OPEN TO ENROLLMENT

Sponsor

Seagen, Inc.

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology